Online personal health records (PHRs) are less frequently used by racial or ethnic minorities and patients with low annual income, according to a study published in the March 28 issue of the Archives of Internal Medicine.
WEDNESDAY, March 30 (HealthDay News) -- Online personal health records (PHRs) are less frequently used by racial or ethnic minorities and patients with low annual income, according to a study published in the March 28 issue of the Archives of Internal Medicine.
Cyrus K. Yamin, from Harvard Medical School in Boston, and colleagues analyzed data from 75,056 patients to compare the demographic characteristics of those registering to use PHRs (adopters) with those who were offered a PHR by a physician but did not register (nonadopters). The intensity of PHR use was measured by the number of logins and secure messages sent, and was analyzed according to demographic characteristics and chronic diseases.
The investigators found that 43 percent of patients adopted PHRs between 2002 and 2009, and an aggressive marketing strategy increased adoption three-fold (odds ratio [OR], 2.92). PHRs were less likely to be adopted by blacks and Hispanics than whites (ORs, 0.50 and 0.64, respectively), and by lower annual income patients than higher income ones. Adopters were more likely to have more than two comorbidities than nonadopters (OR, 1.27). The number of comorbidities, race or ethnicity, and insurance status predicted the intensity of use, but no association was found between income and intensity of use.
"We found the presence of the digital divide in a diverse population. Specifically, racial/ethnic minorities and patients with lower socioeconomic status were less likely to adopt a PHR," the authors write.
One of the study authors disclosed a financial relationship with a medical device company.
AbstractFull Text (subscription or payment may be required)Editorial (subscription or payment may be required)
Related Content
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More